Fibronectin and phagocytic clearance mechanisms.

[1]  P. Vincent,et al.  Kupffer cell complement receptor clearance function after surgical injury and phagocytosis of immune complexes: effect of changes in plasma fibronectin. , 1988, The Journal of laboratory and clinical medicine.

[2]  E. Ruoslahti,et al.  Amino acid sequence of the human fibronectin receptor , 1987, The Journal of cell biology.

[3]  D. Deno,et al.  Reversal of opsonic deficiency in surgical, trauma, and burn patients by infusion of purified human plasma fibronectin. Correlation with experimental observations. , 1986, The American journal of medicine.

[4]  I. Gigli,et al.  The effect of fibronectin on the processing of C1q- and C3b/bi-coated immune complexes by peripheral blood monocytes. , 1986, Journal of immunology.

[5]  R. Hynes,et al.  Molecular biology of fibronectin. , 1985, Annual review of cell biology.

[6]  F. Cosio.  Human fibronectin is an opsonin for IgG antibody-coated sheep erythrocytes. , 1984, The Journal of laboratory and clinical medicine.

[7]  J. O’Shea,et al.  Studies on the fibronectin receptors of human peripheral blood leukocytes. Morphologic and functional characterization , 1984, The Journal of experimental medicine.

[8]  E. Jaffe,et al.  Plasma fibronectin (opsonic glycoprotein): its synthesis by vascular endothelial cells and role in cardiopulmonary integrity after trauma as related to reticuloendothelial function. , 1980, The American journal of medicine.

[9]  F. Blumenstock,et al.  Opsonic α2 Surface Binding Glycoprotein Therapy During Sepsis , 1978 .

[10]  Kenneth M. Yamada,et al.  Fibronectins—adhesive glycoproteins of cell surface and blood , 1978, Nature.

[11]  F. Blumenstock,et al.  Cryoprecipitate reversal of opsonic alpha2-surface binding glycoprotein deficiency in septic surgical and trauma patients. , 1978, Science.

[12]  N. deSmit.  [The doctor's dilemma]. , 1963 .